IP Verse

Medac Gesellschaft Fur Klinische competitive analysis

Loading summary...

Latest oppositions filed by Medac Gesellschaft Fur Klinische

Explore patent oppositions filed by Medac Gesellschaft Fur Klinische against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2478907	Methods And Compositions For Treating Cancer	COUGAR BIOTECHNOLOGY	Jan 11, 2022
EP2493466	Novel Antitumoral Use Of Cabazitaxel	AVENTIS PHARMA	Mar 22, 2021
EP3294285	Cabazitaxel And Its Use For Treating Cancer	AVENTIS PHARMA	Sep 18, 2020

Latest publications and patents of Medac Gesellschaft Fur Klinische New

Explore the latest publications and patents granted to Medac Gesellschaft Fur Klinische, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Medac Gesellschaft Fur Klinische

Discover the latest PTAB cases involving Medac Gesellschaft Fur Klinische, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Medac Gesellschaft Fur Klinische
IPR2014-01091	Jul 1, 2014	ANTARES PHARMA	MEDAC GESELLSCHAFT FUR KLINISCHE	Terminated-Settled

Peer Comparison New

IP litigation analysis comparing Medac Gesellschaft Fur Klinische with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE	3	-	-	-
AVENTIS PHARMA	-	24	-	3
COUGAR BIOTECHNOLOGY	-	22	-	-
SANOFI MATURE	-	24	-	-